(Q54478992)
Statements
Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies. (English)
Adrian Wiestner
8 October 2012
31
1
128-130